HIV & AIDS

Resistance to key HIV drug 'concerningly common'

HIV drug resistance to tenofovir, an antiretroviral drug vital to most modern HIV treatment and prevention strategies, is surprisingly and worryingly common according to a large study led by UCL (University College London) ...

Diseases, Conditions, Syndromes

Scientists homing in on new hepatitis C vaccine

Trinity researchers have just commenced a major new study to evaluate a new vaccine for the prevention of Hepatitis C infection in HIV patients, who are at increased risk of contracting the common infection.

page 14 from 31